Alliance Pharma's growth potential remains underappreciated
Alliance Pharma (APH:AIM) 104pGain to date: 45.3%Original entry point: Buy at 71.6p, 3 October 2019Pharmaceutical specialist Alliance Pharma's (APH:AIM) recent first-half results (21 Sep) demonstrate the strength of the business...
23 September 2021